Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
restor3d has commercialized multiple FDA-cleared personalized orthopedic implant systems using advanced 3D printing and AI-driven design. Their iTotal Identity CR 3DP Porous Total Knee Replacement System received FDA clearance in 2025. The company’s implants are designed to improve fit and function by tailoring each device to the patient’s unique anatomy. Clinical results highlight improved mechanical properties over traditional cast implants and enhanced patient outcomes in joint replacement procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on restor3d.